ADVB Estatísticas principais
Alta
18.73
Abrir
8.32
Volume
23.55M
Baixa
8.08
Fechamento anterior
7.08
Valor negociado
312.10M
52 sem. máx.
18.73
Vol. relativo
5.795
Amplitude (%)
150.42%
52 sem. mín.
3.61
Taxa de giro
1425.97%
Cap. de Mercado
11.69M
P/L (TTM)
44.47
P/L (Anual)
--
P/VP
1.27
P/S
--
Lucro por ação (EPS)
0.159
Dividendo (TTM)
0
Rendimento de dividendos
0.00%
Ações em circulação
1.65M
Unidade monetária
USD
ADVB Desempenho de Preço
7 dia
30 dia
90 dia
180 dia
No acumulado do ano
1 Ano
ADVB Distribuição do fluxo de dinheiro
ADVB Volume diário de venda a descoberto
ADVB Histórico de short interest
ADVB Visão geral da ação
As of 2026-07-22, the Advanced Biomed Inc. (ADVB) stock price today is 12.6179. Based on this price, the company has a market capitalization of $11.69M, with a P/E ratio of 44.47.
On 2026-07-22, ADVB traded between 8.08 and 18.73. Today’s stock price is 56.16% above the daily low and 32.63% below the daily high, placing ADVB perto do meio de its most recent trading range.
Trading volume currently stands at 23.55M, compared with an average daily volume of 4.06M. This suggests that trading activity is significativamente acima do nível habitual than usual.
Over the past year, Advanced Biomed Inc. shares have traded between 3.61 and 18.73. At today’s price, ADVB is 249.53% above its 52-week low and 32.63% below its 52-week high.
ADVB Notícias relacionadas
Sobre ADVB
Nome empresa
Advanced Biomed Inc.
Setor
Health Technology
Indústria
Biotechnology
Trocas
Nasdaq
Número de funcionários
31
Tamanho do lote
100
Site oficial
Unidade monetária
USD
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
Related Stocks
ADVB FAQ
© 2026 CoinGlass, all rights reserved
